Hepatic reticuloendothelial system cells

Hepatic reticuloendothelial system cells comprise a specialized population of phagocytic cells located in the liver—primarily Kupffer cells (liver-resident macrophages) and, in some literature, scavenger endothelial cells lining hepatic sinusoids. These cells play a central role in innate immunity by engulfing and destroying bacteria, clearing nanoparticles and aged red blood cells, metabolizing endotoxins, and presenting antigens. They are a major barrier for intravenously administered particulate drugs and nanomedicines, acting as a functional filter for the bloodstream. Hepatic RES cell function is clinically relevant in infection, inflammation, cancer, and pharmacokinetics of nanoparticle therapeutics. The term 'hepatic reticuloendothelial system cells' does not denote a specific molecular target but an important cellular system influencing drug bioavailability, immune response, and disease progression. Kupffer cells function as immune effectors, while scavenger endothelial cells may also participate in clearance of colloidal stains and nanoparticles. In some contexts, 'reticuloendothelial system' is an older synonym for the broader 'mononuclear phagocyte system,' which includes other tissue macrophages across the body.[1][2][3][4][5] Key points: - Not a molecular/receptor target; refers to liver cell populations. - Most canonical molecular target in this system would be 'Kupffer cell.' - Major therapeutic challenge for intravenous drugs due to their rapid removal from circulation.

Other names

Kupffer cellScavenger endothelial cellHepatic macrophage

Phagocytosis-mediated clearance (removal from systemic circulation); Modulation of immune response (by uptake and processing of particles, including drugs, pathogens, and dying cells); Opsonin-dependent uptake; Alteration of drug pharmacokinetics by rapid removal/biodistribution